ArticleScientific reports2026
Multiple attention based deep multimodal fusion network for glaucoma and neurodegenerative disease diagnosis.
Article in Scientific reports, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
6 authors.
Funding
Abstract
Glaucoma and other neurodegenerative diseases involve progressive damage to the optic disc (OD) and can be identified using visual field (VF) tests, colour fundus photographs (CFP) and optical coherence tomography (OCT). However, most studies overlook neurodegenerative cohorts and primarily rely on unimodal approaches, thus failing to leverage advanced deep multimodal fusion techniques to capture modality-specific features and cross-modal interactions. To address the issue, this study aims to design a multi-attention-based deep multimodal network to fuse functional VF with structural CFP and OCT. Using data from 354 eyes with neuropathies (glaucoma, ischaemic optic neuropathy, dementia and Parkinson’s) and 228 normal eyes, we developed novel deep learning techniques for disc segmentation, fovea localisation, disc-fovea angle calculation and alignment, and multi-attention-based deep intermediate multimodal fusion incorporating different combinations of spatial, self- and cross-modal attention mechanisms. The results indicate that our proposed multi-attention-multimodal fusion network (MAM-Fusion-Net) achieved an area under the sensitivity–specificity curve (AUC) of 0.998 (95% CI 0.996–1.000) for diagnosing neuropathy versus normal participants and 0.981 (95% CI 0.966–0.996) for glaucoma versus non-glaucoma, surpassing state-of-the-art uni- and multi-modal models. This multi-attention-based deep fusion strategy applied to multimodal images shows potential in glaucoma and neurodegenerative disease diagnosis to assist eye care practitioners.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.